KR100340761B1 - Resolution method for preparing l-muscone stereoselectively - Google Patents

Resolution method for preparing l-muscone stereoselectively Download PDF

Info

Publication number
KR100340761B1
KR100340761B1 KR1020000024819A KR20000024819A KR100340761B1 KR 100340761 B1 KR100340761 B1 KR 100340761B1 KR 1020000024819 A KR1020000024819 A KR 1020000024819A KR 20000024819 A KR20000024819 A KR 20000024819A KR 100340761 B1 KR100340761 B1 KR 100340761B1
Authority
KR
South Korea
Prior art keywords
muscon
ketal
iii
stereoselectively
separating
Prior art date
Application number
KR1020000024819A
Other languages
Korean (ko)
Other versions
KR20000049980A (en
Inventor
김권
박무신
이승용
유정환
Original Assignee
김권
우리켐테크(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김권, 우리켐테크(주) filed Critical 김권
Priority to KR1020000024819A priority Critical patent/KR100340761B1/en
Publication of KR20000049980A publication Critical patent/KR20000049980A/en
Application granted granted Critical
Publication of KR100340761B1 publication Critical patent/KR100340761B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 3-메칠 시클로펜타데칸-1-온(Ⅱ)에 트레이톨 유도체들을 반응하여dl-무스콘 케탈 화합물(Ⅲ)을 만든 후 이를 가수분해하여l-무스콘(I)을 분리 정제하는 방법에 있어서, 순상 크로마토그래피 조건 하에서dl-무스콘 케탈 화합물(Ⅲ)을 분취한 후 이를 가수분해하여 입체선택적으로l-무스콘(I)을 분리 정제하는 방법을 제공하는 것이다.In the present invention, dl -muscon ketal compound (III) is made by reacting pentitol derivatives with 3-methylcyclopentadecan-1-one (II), and then hydrolyzed to separate l -muscon (I). In the method, a dl -muscon ketal compound (III) is collected under normal phase chromatography conditions and then hydrolyzed to provide a method for stereoselectively separating l -muscon (I).

(반응식 1)(Scheme 1)

상기식에서 R1은 아래 구조식의 관능기를 나타낸다.In formula, R <1> represents the functional group of the following structural formula.

Description

엘-무스콘의 광학활성 분리 정제 방법{Resolution method for preparing l-muscone stereoselectively}Solution method for preparing l-muscone stereoselectively}

본 발명은l-무스콘 광학활성체의 분리 정제 방법에 관한 것이다. 더욱 상세히는,dl-무스콘 라세미체에 트레이톨 유도체들을 반응하여dl-무스콘 케탈을 형성한 뒤 컬럼 크로마토그래피를 이용하여 광학활성체를 분리시키는 방법에 있어서, 컬럼의 종류 및 용리수의 선택을 통해 효율적인 방법으로 고순도의l-무스콘 광학활성체를 높은 수율로 입체선택적으로 분리 정제하는 방법에 관한 것이다.The present invention relates to a method for separating and purifying l -muscon optically active material. Still more particularly, dl - no scones la by reacting tray tolyl derivative in racemic dl - no scones using a back column chromatography to form a ketal according to the method of separating the optically active substance, the type of column and eluted number of The present invention relates to a method for stereoselectively separating and purifying high purity l -muscon optically active substance in high yield through selection.

사향은 강심, 진정, 중추신경 흥분 등의 효과가 있어 국내에서 우황청심원,기응환 등의 의약원료로 사용되고 있으며 전량 수입에 의존하고 있었으나, 지난 96년 10월부터 CITES(멸종동물 국제거래에 대한 보호협약) 발효에 따라 사실상 국내 수입이 금지되어 대체물질 개발이 국내업계의 시급한 과제중의 하나이다(약업신문 '97.6.26).Musk has the effect of strong heart, soothing, central nervous excitement, so it is used in Korea as a pharmaceutical ingredient such as wowang cheongsimwon and Ki Eung Hwan and has been relying on total imports, but since October 1996, CITES (Protection Agreement on International Trade in Endangered Animals) As a result of the entry into force, domestic imports are virtually banned, and the development of alternative materials is one of the urgent tasks of the domestic industry (Pharmaceutical Newspaper '97 .6.26).

현재 일부 제약회사에서 사향 대체물질로써 천연사향에 함유되어 있는l-무스콘의 합성품이 사향과 약효발현에 있어서 동등성을 입증받아 우황청심원 등에 대체 처방되고 있으나, 하기 구조식 (1)에서 보는 바와 같이 3번-탄소위치 메틸 그룹을 입체 선택적으로 도입하기가 쉽지 않아 95% 에난티오머 엑세스(Enantiomer excess) 이상의 순수한 광학활성을 갖는l-무스콘의 대량생산 공업화 가능 공정연구가 필수적이다.Currently, some pharmaceutical companies have synthesized l -muscon in natural musk as a substitute for musk, and has been proved to be equivalent in musk and drug expression, and has been replaced by Wu Hwang Cheongsimwon, but as shown in Structural Formula (1) below, -It is not easy to introduce the carbon-position methyl group in three-dimensionally selective, so it is essential to study the mass production industrialization process of l -muscon with pure optical activity of more than 95% enantiomer excess.

(식 1)(Equation 1)

지금까지 라세미체(racemate)로서dl-무스콘의 합성은 많은 경제적이고 합리적인 공정이 발표된바 있으나[Angew. Chem.,69, 397 (1957) ;Tetrahedron Letters, 2257 (1979) ;Tetrahedron Letters,32, 565 (1991)],시클로펜타데칸온(Cyclopentadecanone)을 출발물질로 α,β-불포화 시클로펜타데크-2-엔온(α,β-unsaturated Cyclopentadec-2-enone)을 거쳐 3번-탄소위치 메틸레이션(Methylation)법이 가장 효과적인 합성법으로 알려져 있다(반응식 2).Until now, the synthesis of dl -muscon as a racemate has been published for many economic and reasonable processes [ Angew. Chem. 69 , 397 (1957); Tetrahedron Letters , 2257 (1979); Tetrahedron Letters , 32 , 565 (1991)], through cyclopentadecanone as α, β-unsaturated Cyclopentadec-2-enone as α, β-unsaturated Cyclopentadec-2-enone Carbon position methylation is known to be the most effective synthesis method (Scheme 2).

(반응식 2)(Scheme 2)

그러나 반응식 2의 합성공정에 의해dl-무스콘 라세미체를 공업적으로 경제적인 방법에 의해 상업 생산한다 하더라도 물질 구조상 화학적 방법에 의해 광학활성 분리할 수 없고 의약품 등에서l-무스콘 만이 순수하게 사용가능하며 따라서 입체 선택적l-무스콘 제조 방법 연구가 중요한 과제로 부각되었다.However, even though commercial production of dl -muscon racemate by the economical method by the synthesis process of Scheme 2, it is not possible to optically separate by chemical method due to the material structure, and only l -muscon is used purely in medicine. It is possible, and therefore, the study of the method for producing stereoselective l -muscon has emerged as an important task.

종래의 광학 활성을 지닌l-무스콘 합성법은 주로 학문적 관점에서 입체선택적 메틸레이션 방법에 초점을 맞추어 왔으며 반응식 2에서 보는 바와 같이 합성공정이 너무 복잡하거나 화학적, 광학적 순도가 만족스럽지 못하며 구하기 어려운 출발물질을 사용하는 등의 결점이 있어 본격적인l-무스콘의 공업화 상업생산에 응용하지 못하고 있었다.Conventional optically active l -muscon synthesis method has focused mainly on stereoselective methylation methods from an academic point of view. As shown in Scheme 2, the synthesis process is too complicated, chemical or optical purity is not satisfactory, and difficult to obtain starting materials. There was a flaw, such as the use of l -muscon, which could not be applied to the industrialized commercial production of muscon.

ⅰ) Asymmetric conjugate addition of CH3Li ; J.C.S. Perkin I, 1193 (1992)에 개시된 사항을 도식화하면 다음과 같다.Viii) Asymmetric conjugate addition of CH3Li; J.C.S. Schematic of what is disclosed in Perkin I, 1193 (1992) is as follows.

(반응식 2-1)(Scheme 2-1)

ⅱ) Diastereoselective cyclopropanation of enoens ; J.A.C.S., 107, 8256(1985)에 개시된 사항을 도식화하면 다음과 같다.Ii) Diastereoselective cyclopropanation of enoens; Schematic of what is disclosed in J.A.C.S., 107, 8256 (1985) is as follows.

(반응식 2-2)(Scheme 2-2)

상기한 바와 같이 키랄 리간드(Chiral ligand)를 이용하거나 적당한 입체방어적 관능기 도입에 의한 입체선택적 반응으로l-무스콘을 합성하는 방법은 고가의 반응시약을 사용하면서도 공업적으로 적용하기 어려운 공정을 포함한다. 한편으로는, 상기 반응은 그 합성 경로가 길고 또한 광학활성 역시 85% 에난티오머 엑세스 이하인 경우에는 상용화에 만족스럽지 못한 결과를 보이므로, 중간체 및l-무스콘의 분리정제 과정이 필요하게 되어 학문적 관점에서의 가치를 제외하고는 상용화하기에 부적합한 비경제적인 합성방법이다.As described above, the method of synthesizing l -muscon using a chiral ligand or a stereoselective reaction by introducing an appropriate stereoprotective functional group includes a process that is difficult to apply industrially while using an expensive reaction reagent. do. On the other hand, the reaction is unsatisfactory for commercialization when the synthesis route is long and the optical activity is less than 85% enantiomer access. Therefore, the intermediate and l -muscon separation and purification processes are required. Except for its value in terms of value, it is an uneconomical synthesis that is not suitable for commercialization.

한편 대한민국 등록특허공보 제226,622호에서는dl-무스콘 라세미체에 1,4-디-O-벤질-2,3-D-트레이톨과 반응하여 케탈을 형성한 뒤 역상 크로마토그래피(컬럼 C18, 이동상 아세토니트릴-물 혼합액 85%)조건에서 실시하였으나 이 물질은 극성 유기 용매에의 용해도가 극히 낮기 때문에 샘플 로딩(loading)양이 적고 런 타임(run time)이 길어 실질적으로 상업적으로 이용하기가 어려운 단점이 있었다.Meanwhile, Korean Patent Publication No. 226,622 discloses ketal by reacting with 1,4-di-O-benzyl-2,3-D-thritol in dl -muscon racemate, followed by reverse phase chromatography (column C 18). , 85% of mobile phase acetonitrile-water mixture), but this material has very low solubility in polar organic solvents, so it has a low sample loading and a long run time, making it practical for commercial use. There was a hard disadvantage.

본 발명이 이루고자 하는 기술적 과제는 이미 공지된dl-무스콘 라세미체에 1,4-디-O-벤질-2,3-D-트레이톨과 반응하여 케탈을 형성한 뒤 역상 크로마토그래피 조건에서 실시시 상기 물질이 극성 유기 용매에의 용해도가 극히 낮기 때문에 샘플 로딩양이 적고 런 타임이 길어 실질적으로 상업적으로 이용하기가 어려운 단점을 극복하여 효율적인 방법으로l-무스콘만을 입체선택적으로 분리 정제하기 위한 크로마토그래피 조건을 완성한 것이다.The technical problem to be achieved by the present invention is to react with 1,4-di-O-benzyl-2,3-D-thritol in dl -muscon racemate already known to form a ketal and then in reverse phase chromatography conditions. to separate only non-scones in stereoselective tablet-conducted when the material is low sample loading amount of run time increases substantially in a commercially efficient way to overcome the difficult disadvantages to using l because of the polar organic solubility of the solvent is extremely low Chromatography conditions were completed.

따라서 본 발명의 목적은 3-메칠 시클로펜타데칸-1-온(Ⅱ)에 트레이톨 유도체들을 반응하여dl-무스콘 케탈 화합물(Ⅲ)을 만든 후 이를 가수분해하여l-무스콘(I)을 분리 정제하는 방법에 있어서, 순상 크로마토그래피 조건 하에서dl-무스콘 케탈 화합물(Ⅲ)을 분취한 후 이를 가수분해하여 입체선택적으로l-무스콘(I)을분리 정제하는 방법을 제공하는 것이다.Accordingly, an object of the present invention is to react hydroxyl derivatives to 3-methyl cyclopentadecan-1-one (II) to form dl -muscon ketal compound (III), and then hydrolyze them to form l -muscon (I). In the separation and purification method, dl -muscon ketal compound (III) is fractionated under normal phase chromatography conditions and then hydrolyzed to provide a method for stereoselectively separating l -muscon (I).

(반응식 1)(Scheme 1)

상기식에서 R1은 아래 구조식의 관능기를 나타낸다.In formula, R <1> represents the functional group of the following structural formula.

한편, 상기 분취 크로마토그래피 방법에서 이동상으로써의 용매의 조성은 테트라하이드로퓨란(THF) : 시클로헥산 = (0∼10% : 100∼90%)이거나 테트라하이드로퓨란(THF) : 노말헥산(n-Hexane) = (0∼10% : 100∼90%)인 순상 컬럼 조건하에서 분리함을 특징으로 한다.On the other hand, the composition of the solvent as the mobile phase in the preparative chromatography method is tetrahydrofuran (THF): cyclohexane = (0-10%: 100-90%) or tetrahydrofuran (THF): normal hexane (n-Hexane ) Under (0-10%: 100-90%) pure phase column conditions.

이하 본 발명을 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail.

종래의 경우 광학활성 분리가 가능하도록dl-무스콘에 도입한 케톤의 입체선택적 관능기에 대해 3번 탄소위치 메틸기가 상대적으로 화합물 전체 화학적 물성에 주는 차이가 미미하여, 도입하는 관능기는 보다 분자크기가 큰 화합물을 선택하여야 하였으며 에스테르기 등 다른 관능기를 보유할 경우 중합반응 등 원하지 않는 부반응물을 생성하는 등의 문제를 해결한 것이다.In the conventional case, the carbon-substituted methyl group on the chemical properties of the compound is relatively insignificant with respect to the stereoselective functional group of the ketone introduced into the dl -muscon to enable optically active separation, so that the functional group to be introduced has a larger molecular size. It was necessary to select a compound and solve the problem of generating unwanted side reactions such as polymerization reaction when having other functional groups such as ester groups.

이에 천연물 등에서 쉽게 얻을 수 있는 L-타르타르산 에스테르(L-Tartaric acid ester)로부터 쉽게 합성 가능한 D-트레이톨 유도체들을dl-무스콘에 반응하여 케탈을 형성했을 때 컬럼 등에서 광학활성 분리가 가능함을 확인, 집중적으로 분리조건을 연구하게 되었고 테트라하이드로퓨란(THF) / 시클로헥산, 테트라하이드로퓨란(THF) / 노말헥산(n-Hexane) 이동상의 순상 컬럼 조건을 확보하여, 역상 조건에서보다 많은 로딩(Loading)량 등 경제적인 면에서 우수한 결과를 확인하였다.Therefore, it was confirmed that optically separated on a column or the like when D-thritol derivatives easily synthesized from L-Tartaric acid ester, which are easily obtained from natural products, were reacted with dl -muscon to form a ketal. Intensive study of the separation conditions, and secured the normal phase column conditions of the tetrahydrofuran (THF) / cyclohexane, tetrahydrofuran (THF) / normal hexane (n-Hexane) mobile phase, loading more than the reverse phase conditions Excellent results in terms of amount and economics were confirmed.

이때 컬럼 크로마토그래피 방법은 테트라하이드로퓨란(THF)/시클로헥산의 비율 0~10%, 테트라하이드로퓨란(THF)/노말헥산(n-Hexane)의 비율 0~10%의 순상 조건이다. 역상 조건에서는 분리 후 용매 재 추출 공정, 낮은 용해도에 따른 적은양의 로딩 및 런 타임이 길어 공정화에는 적합하지 못하였다.At this time, the column chromatography method is a net phase condition of the ratio of tetrahydrofuran (THF) / cyclohexane 0-10%, the ratio of tetrahydrofuran (THF) / normal hexane (n-Hexane) 0-10%. In reverse phase conditions, solvent re-extraction after separation, low loading due to low solubility, and long run time were not suitable for the process.

실시예를 통해 본 발명을 더욱 상세히 기술하면 다음과 같다.The present invention will be described in more detail with reference to the following Examples.

(시약 및 기기)(Reagents and devices)

실험에 사용된 시약 중 시클로펜타데칸온은 알드리치 시그마사의 제품을 사용하였으며 다른 필요시약은 특급시약을 구입하여 사용하였고 기타 용매류는 알려진 방법에 의해 정제하여 사용하였다. 모든 실험의 진행사항은 TLC로 관찰하였고 얻어진 중간 물질들의 순도는 HPLC로 확인하였다. 이때 HPLC의 컬럼은 Silica SG80A, 4.6 X 250mm, 5μ, Shiseido사 것을 사용하였고 비선광도(Specific rotation) 측정은 JASCO사의 편광계(Polarimeter)를 사용하였다.Among the reagents used in the experiment, cyclopentadecanone was used by Aldrich Sigma Co., Ltd. and other necessary reagents were purchased by using a special reagent, and other solvents were purified by a known method. The progress of all experiments was observed by TLC and the purity of the intermediates obtained was confirmed by HPLC. At this time, the column of HPLC used Silica SG80A, 4.6 X 250mm, 5μ, Shiseido Inc., and the specific rotation was measured using JASCO Polarimeter.

특히 l-무스콘의 에난티오머 엑세스(ee %)는 HPLC를 이용하여 보다 정확히 측정하였다. 이때 사용한 컬럼은 Chiralpak AS, Daicel이다. 사용한 HPLC 기기는 Shiseido사 제품이다. 합성과정 중 모든 화합물들은 1H-NMR과 13C-NMR을 사용하여 구조를 확인하였다. 이때 사용한 기종은 Varian, 200MHz NMR 스펙트로미터이다. 모든 화합물은 CDCl3 동일 용매로 용해하였으며, 화학적이동은 1H 스펙트럼의 경우 내부표준물질인 테트라메틸실란(Tetramethylsilane : TMS)으로부터의 δ값(ppm)으로 나타내었으며, 13C 스펙트럼의 경우는 내부표준물질로 CDCl3(77.0)를 사용하였고 δ값(ppm)으로 나타내었다. GC-MSD(Mass selective detector)는 HP5970 MSD를 사용하였다. 이때 사용한 컬럼은 SE-54이고, 운반 기체인 헬륨은 1.0 mL/min의 유속이며 주입구의 온도는 280℃, 검출기는 300℃ 이었다. UV/Vis 스펙트로미터는 JASCO를 사용하였다.In particular, enantiomer access (ee%) of l-muscon was more accurately measured using HPLC. The column used was Chiralpak AS, Daicel. The HPLC instrument used is from Shiseido. During the synthesis, all compounds were identified by 1H-NMR and 13C-NMR. The model used at this time is a Varian, 200MHz NMR spectrometer. All compounds were dissolved in the same solvent of CDCl3, and chemical shifts were expressed as δ (ppm) from tetramethylsilane (TMS), an internal standard for the 1H spectrum, and CDCl3 as an internal standard for the 13C spectrum. (77.0) was used and expressed as δ (ppm). The mass selective detector (GC-MSD) used HP5970 MSD. The column used was SE-54, a carrier gas of helium, a flow rate of 1.0 mL / min, an inlet temperature of 280 ° C, and a detector of 300 ° C. UV / Vis spectrometer used JASCO.

(실시예 1)dl-무스콘 케탈(Ⅲ)의 합성 및 분리Example 1 Synthesis and Separation of dl -Muscon Ketal (III)

둥근 삼구 플라스크에 3-메틸시클로펜타데칸-1-온(0.738g), 1,4-디-O-벤질-D-트레이톨(1.05g)과 p-톨루엔-술폰산 모노하이드레이트(p-toluene-sulfonic acid monohydrate:0.329g)를 벤젠(25mL) 용매에 녹여 넣은 후 질소 분위기 하에서 환류하면서 반응한다. 딘-스타크 트랩(Dean-Stark trap)을 장착하여 Azeotropically H2O를 제거 한다. TLC(헥산:에틸아세테이트=9:1) 분석을 통하여 출발 물질이 모두 소진 될 때 까지 반응한다. 반응 용액을 실온으로 냉각한 후 에테르 용매로 추출한다. 이 유기층을 분별 깔대기에 옮겨 포화 NaHCO3와 브라인으로 잘 세척한 후 무수 MgSO4로 수분을 제거하고 감압하에 용매를 날려 조생성물을 얻은 후 실리카겔 컬럼 크로마토그래피(헥산:에틸아세테이트=9:1)를 실시하여 3-메틸시클로펜타데칸-1-온-1,4-디-O-벤질-D-트레이톨 케탈(Ⅲ) 1.88g (86%)을 얻었다.3-methylcyclopentadecan-1-one (0.738 g), 1,4-di-O-benzyl-D-thritol (1.05 g) and p-toluene-sulfonic acid monohydrate (p-toluene-) in a round three-neck flask sulfonic acid monohydrate: 0.329g) is dissolved in benzene (25mL) solvent and reacted under reflux under nitrogen atmosphere. Fit a Dean-Stark trap to remove Azeotropically H 2 O. TLC (hexane: ethyl acetate = 9: 1) analysis is used until the starting material is used up. The reaction solution is cooled to room temperature and then extracted with ether solvent. The organic layer was transferred to a separatory funnel and washed well with saturated NaHCO 3 and brine, followed by removal of water with anhydrous MgSO 4 , blowing solvent under reduced pressure to obtain a crude product, followed by silica gel column chromatography (hexane: ethyl acetate = 9: 1). 1.88 g (86%) of 3-methylcyclopentadecan-1-one-1,4-di-O-benzyl-D-thritol ketal (III) was obtained.

1H-NMR(CDCl3, δ) 0.95 (3, d, JHH=6.2Hz, 더블렛(Doublet) 피이크가 갈라지는 현상은 이성질체(Diastereomer)의 피이크가 각기 나타남), 1.3-1.7 (27, m),3.62 (4, d), 4.01 (2, t), 4.58 (4, s), 7.35 (10, 2 phenyl)1H-NMR (CDCl3, δ) 0.95 (3, d, JHH = 6.2Hz, Doublet peak splitting results in peaks of isomers, respectively), 1.3-1.7 (27, m), 3.62 (4, d), 4.01 (2, t), 4.58 (4, s), 7.35 (10, 2 phenyl)

위에서 얻어진 3-메틸시클로펜타데칸-1-온-1,4-디-O-벤질-D-트레이톨 케탈 이성질체 화합물을 분리하기 위하여 분취 크로마토그래피 시스템을 적용하였다. 컬럼은 SILICA AG80 S-20, 10mm X 250mm X 2,(Shiseido)를 사용하였으며 검출파장은 258nm, 용매의 조성은 1.0% THF/노말헥산, 유속은 5mL/min 온도는 상온에서이다. 주입하는 시료 양이 30mg이고 런 타임 (run time)은 120분이다. 앞에 나오는 피이크는 [α]d +5.99(c=1.0, CHCl3)인 (+)-3-메틸시클로펜타데칸-1-온-1,4-디-O-벤질-D-트레이톨케탈((+)-3-Methylcyclopentadecan-1-one-1,4-Di-O-benzyl-D-threitol ketal)이고 뒤에 나온 피이크는 [α]d -3.92 (c=1.0,CHCl3)인 (-)-3-메틸시클로펜타데칸-1-온-1,4-디-O-벤질-D-트레이톨케탈((-)-3-Methylcyclopentadecan-1-one-1,4-Di-O-benzyl-D-threitol ketal)이다.A preparative chromatography system was applied to separate the 3-methylcyclopentadecan-1-one-1,4-di-O-benzyl-D-thritol ketal isomeric compound obtained above. The column used SILICA AG80 S-20, 10mm X 250mm X 2, (Shiseido), the detection wavelength is 258nm, the composition of the solvent is 1.0% THF / normal hexane, the flow rate is 5mL / min at room temperature. The sample injected is 30 mg and the run time is 120 minutes. The preceding peak is (+)-3-methylcyclopentadecan-1-one-1,4-di-O-benzyl-D-thritol ketal, which is [α] d +5.99 (c = 1.0, CHCl 3). +)-3-Methylcyclopentadecan-1-one-1,4-Di-O-benzyl-D-threitol ketal) and the following peak is (-)-3 with [α] d -3.92 (c = 1.0, CHCl3) -Methylcyclopentadecan-1-one-1,4-di-O-benzyl-D-thritol ketal ((-)-3-Methylcyclopentadecan-1-one-1,4-Di-O-benzyl-D- threitol ketal).

또한 컬럼의 길이(250mm X 3)를 1.5배 증가시키면 1.2% 테트라하이드로퓨란(THF)/노말헥산에서 로딩(loading)양은 60mg으로 두배 증가하고 런 타임(run time)은 180분이다. 따라서 컬럼 크기에 따른 로딩(loading)양은 다음 표 1과 같다.In addition, increasing the length of the column (250 mm × 3) by 1.5 times doubled the loading in 1.2% tetrahydrofuran (THF) / normal hexane to 60 mg and the run time was 180 minutes. Therefore, the loading amount according to the column size is shown in Table 1 below.

(표 1)Table 1

컬럼크기Column size 100mm100 mm 200mm200 mm 300mm300 mm 400mm400 mm 로딩(loading)양Loading amount 6g6 g 24g24 g 54g54 g 96g96g

용매의 조성을 테트라하이드로퓨란(THF)/시클로헥산, 에틸아세테이트/노말헥산 및 에틸아세테이트/시클로헥산의 조건에서는 1.2% THF/노말헥산의 경우보다 리텐션 타임(retention time) 등에서 불리한 조건임을 확인하였다.The composition of the solvent was found to be more adverse in terms of retention time than in the case of tetrahydrofuran (THF) / cyclohexane, ethyl acetate / normal hexane and ethyl acetate / cyclohexane than 1.2% THF / normal hexane.

(비교 실시예 1) 역상 크로마토그래피 조건에서dl-무스콘 케탈(Ⅲ)의 분리Comparative Example 1 Separation of dl -muscon ketal (III) under reversed phase chromatography conditions

실시예 1에서 얻어진 3-메틸시클로펜타데칸-1-온-1,4-디-O-벤질-D-트레이톨 케탈을 분취 역상 크로마토그래피 시스템인 컬럼(C18,ODS) 10mm X 250mm X2 C18UG80(S-20) Shiseido, 검출 파장 258nm, 유속 5mL/min, 상온에서 분리한 결과 어느 정도의 분리 효과를 보기 위해서는 90% 아세토니트릴의 이동상에서이고 런 타임(run time)은 240분이 된다. 이때 로딩(loading)양은 4mg이다. 따라서 컬럼의 크기가 100mm로 커진다 할지라도 로딩(loading)양은 0.4g이다. 이 조건 하에서는 분리된 무스콘 케탈을 얻기 위해서는 유기 용매로 재 추출을 해야 될 뿐만 아니라l-무스콘 케탈(Ⅲ)의 용해도가 낮아서 로딩양이 너무 적어 상업적으로 이용하기가 어렵다.The 3-methylcyclopentadecan-1-one-1,4-di-O-benzyl-D-thritol ketal obtained in Example 1 is a preparative reverse phase chromatography system (C18, ODS) 10 mm X 250 mm X2 C18UG80 ( S-20) Shiseido, detection wavelength 258nm, flow rate 5mL / min, separation at room temperature. To see some separation effect, 90% acetonitrile in mobile phase and run time is 240 minutes. At this time, the loading amount is 4mg. Therefore, even if the column size increases to 100 mm, the loading amount is 0.4 g. Under these conditions, in order to obtain the separated mousse ketal, not only the re-extraction with an organic solvent, but also the low solubility of l -muscon ketal (III) is difficult to use commercially because the loading amount is too small.

위의 결과로부터 고순도의 무스콘 이성질체가 분리가능하다는 것을 발견하였다. 그러나, 극성 유기 용매에의 용해도가 극히 낮기 때문에 샘플 부하량이 적고 정제시간이 길다는 점에서 판단해 보면, 역상모드에서의 정제는 효율적이라고 간주할 수 없다. 또한, 내경 100 mm, 길이 500 mm의 분취 컬럼을 이용할 때 1회 샘플 부하량은 0.38 g이고, 각각의 이성체가 100% 회수된다고 해도 0.2 g 이하라는 계산이 된다. 더욱이 1회의 정제시간은 4시간 이상이다.From the above results, it was found that high purity muscon isomers are separable. However, since the solubility in polar organic solvents is extremely low, the purification in the reversed phase mode cannot be regarded as efficient in view of the fact that the sample load is small and the purification time is long. Further, when a preparative column having an inner diameter of 100 mm and a length of 500 mm is used, the single sample load is 0.38 g, and even if each isomer is recovered 100%, it is calculated to be 0.2 g or less. Moreover, one purification time is more than four hours.

따라서 다른 분취 방법을 선택하는 편이 현명하다고 생각된다. 그 대안으로 순상모드에서의 분취를 고려할 수 있고, 이에 따라 실험한 결과 실시예와 같은 우수한 실험결과를 얻었다.Therefore, it is wise to choose another preparative method. As an alternative, preparative phase in the normal phase mode may be considered. As a result, the same experimental results as in Example were obtained.

본 발명의 효과는 공업적으로 상업생산 가능한 유용한 광학활성을 지니는l-무스콘 합성공정을 개발하고자 이미 공업적으로 경제적인 방법으로 상업생산이 가능한dl-무스콘 라세미체와 트레이톨(threitol) 유도체들을 반응시키면dl-무스콘 케탈 라세미체에서 선택적으로l형의 광학활성체를 순상 분취 크로마토그래피 방법으로 분리할 수 있음을 착안하여 대량생산 방법을 제공하게 된 것이다.The effect of the present invention is that dl -muscon racemate and threitol which are already commercially available in an industrially economical way to develop l -muscon synthesis process having useful optical activity that can be industrially produced commercially. By reacting the derivatives, it was possible to selectively separate the l- type optically active substance from the dl -muscon ketal racemate, thereby providing a mass production method.

Claims (2)

3-메칠 시클로펜타데칸-1-온(Ⅱ)에 트레이톨 유도체들을 반응하여dl-무스콘 케탈 화합물(Ⅲ)을 만든 후 이를 가수분해하여l-무스콘(I)을 분리 정제하는 방법에 있어서, 순상 크로마토그래피 조건 하에서dl-무스콘 케탈 화합물(Ⅲ)을 분취한 후 이를 가수분해하여 입체선택적으로l-무스콘(I)을 분리 정제하는 방법.In a method of separating and purifying l -muscon (I) by reacting 3-methylcyclopentadecan-1-one (II) with pentol derivatives to form dl -muscon ketal compound (III) and then hydrolyzing them , And separating dl -muscon ketal compound (III) under normal phase chromatography conditions and then hydrolyzing it to stereoselectively separate l -muscon (I). (반응식 1)(Scheme 1) 상기식에서 R1은 아래 구조식의 관능기를 나타낸다.In formula, R <1> represents the functional group of the following structural formula. 제 1항에 있어서, 상기 분취 크로마토그래피 방법에서 이동상으로써의 용매의 조성은 테트라하이드로퓨란(THF) : 시클로헥산 = (0∼10% : 100∼90%)이거나 테트라하이드로퓨란(THF) : 노말헥산(n-Hexane) = (0∼10% : 100∼90%)인 순상 컬럼 조건하에서 분리함을 특징으로 하는 입체선택적으로l-무스콘(I)을 분리 정제하는 방법.The method of claim 1, wherein the composition of the solvent as the mobile phase in the preparative chromatography method is tetrahydrofuran (THF): cyclohexane = (0 to 10%: 100 to 90%) or tetrahydrofuran (THF): normal hexane (n-Hexane) = (0 to 10%: 100 to 90%) A method for separating and purifying l -muscon (I) by stereoselective, characterized in that the separation under the normal column conditions.
KR1020000024819A 2000-05-10 2000-05-10 Resolution method for preparing l-muscone stereoselectively KR100340761B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020000024819A KR100340761B1 (en) 2000-05-10 2000-05-10 Resolution method for preparing l-muscone stereoselectively

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020000024819A KR100340761B1 (en) 2000-05-10 2000-05-10 Resolution method for preparing l-muscone stereoselectively

Publications (2)

Publication Number Publication Date
KR20000049980A KR20000049980A (en) 2000-08-05
KR100340761B1 true KR100340761B1 (en) 2002-06-20

Family

ID=19668305

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020000024819A KR100340761B1 (en) 2000-05-10 2000-05-10 Resolution method for preparing l-muscone stereoselectively

Country Status (1)

Country Link
KR (1) KR100340761B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020038220A (en) * 2000-11-17 2002-05-23 여언례 Separation of l-muscone and d-muscone from muscone racemate by resolution method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010099122A (en) * 2001-09-03 2001-11-09 김권 Resolution process for preparing l-muscone or d-muscone
KR100625886B1 (en) * 2004-06-23 2006-09-20 박옥순 Purifying method of l-muscone or d-muscone using stereo-selectively separating method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020038220A (en) * 2000-11-17 2002-05-23 여언례 Separation of l-muscone and d-muscone from muscone racemate by resolution method

Also Published As

Publication number Publication date
KR20000049980A (en) 2000-08-05

Similar Documents

Publication Publication Date Title
Flann et al. Enantioselective total synthesis of streptazolin. The tandem use of iminium ion vinylsilane cyclizations and intramolecular acylations
CA2818225C (en) Processes for preparation of everolimus and intermediates thereof
EP0045118A2 (en) Intermediates for the synthesis of bicyclo (2,2,1) heptanes and bicyclo (2,2,1) hept-2Z-enes
AU2012601A (en) Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
CN112739683B (en) Preparation method of brivaracetam and intermediate thereof
FR2776292A1 (en) Novel cephalotaxane derivatives with a side chain
Avenoza et al. Enantioselective synthesis of (S)-and (R)-α-methylserines: application to the synthesis of (S)-and (R)-N-Boc-N, O-isopropylidene-α-methylserinals
JP2008508193A (en) Method for producing optically active compound
KR100340761B1 (en) Resolution method for preparing l-muscone stereoselectively
Kitazume et al. A highly stereocontrolled synthetic approach to 1, 6-dideoxy-6, 6-difluoroazasugar derivatives
Sommer et al. Solid‐Phase Synthesis of [5.5]‐Spiroketals
MacLeod et al. A short enantioselective synthesis of a biologically active compound from Persea americana
EP0998470B1 (en) Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
Hanselmann et al. Enantioselective Synthesis of a Wieland-Miescher Ketone Bearing an Angular Hydroxymethyl Group
US4158012A (en) Steroid synthesis process using mixed anhydride
WO2002022618A1 (en) Method for preparing camptothecin and its derivatives
US4764641A (en) Process for preparing optically active carbonyl compounds
Kotsuki et al. Synthesis of lateral root-inducing compounds using an efficient coupling reaction of chiral triflates
Rose et al. Synthesis of chiral acetylenic analogs of the plant hormone abscisic acid
Kagoshima et al. Copper (II) triflate-mediated addition reaction of α-oxygenated alkylstannanes to imines for the synthesis of vicinal-amino alcohol derivatives
US5380849A (en) Process for optically pure decahydroisoqiunolines
JP3440305B2 (en) 7- (N-substituted amino) -2-phenylheptanoic acid ester derivative and method for producing the derivative
CN113710674B (en) Diastereoselective process for preparing maytansinoids containing thiols or disulfides and intermediates thereof
CN114341098B (en) Method for producing cyclopentane compound, method for producing lactone compound, method for producing diol compound, and compound
FR2460951A1 (en) PROCESS FOR THE PREPARATION OF 15-HYDROXYIMINO-E-HOMOEBURNANE DERIVATIVES AND COMPOUNDS OBTAINED THEREBY

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee
R401 Registration of restoration
LAPS Lapse due to unpaid annual fee
R401 Registration of restoration
FPAY Annual fee payment

Payment date: 20120604

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee